8th Heinrich-Warner-Foundation-Symposium H. HulandR. Hautmann Editorial 01 September 2004 Pages: 117 - 117
Prognostic factors in renal cell carcinoma Börje Ljungberg Main Topic 01 September 2004 Pages: 119 - 120
Early and late genetic changes in clear cell renal carcinoma Holger Moch Main topic 01 September 2004 Pages: 121 - 121
Current limitations of radiofrequency ablation in renal cell carcinoma Michael A. S. Jewett Main topic 01 September 2004 Pages: 122 - 123
Prediction of site-specific metastases in surgically treated nonmetastatic renal cell cancer I. FrankH. Zincke Main Topic 01 September 2004 Pages: 125 - 128
Human renal cell carcinoma inhibits dendritic cell maturation and functions E. Y. SongM. R. ShurinG. V. Shurin Main topic 01 September 2004 Pages: 128 - 130
Tumor-induced dysfunction in T lymphocytes: increased sensitivity to apoptosis J. H. FinkeC. TannenbaumR. Bukowski Main topic 01 September 2004 Pages: 131 - 132
The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients Dolores J. SchendelC. S. FalkH. Pohla Main Topic 01 September 2004 Pages: 133 - 135
Predicting survival of patients with metastatic renal cell carcinoma R. J. MotzerM. Mazumdar Main topic 01 September 2004 Pages: 135 - 136
HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC J. A. EllerhorstW. H. HildebrandE. A. Grimm Main topic 01 September 2004 Pages: 137 - 137
Therapeutic approaches in metastatic renal cell carcinoma: local immunotherapy Edith HulandH. HeinzerH. Huland Main Topic 01 September 2004 Pages: 140 - 144
Target-specific therapy requires target-specific populations in the treatment of renal cell carcinoma Robert A. FiglinH. AlvinC. L. Meinhardt Main topic 01 September 2004 Pages: 144 - 145
Cytotoxic chemotherapy for metastatic renal cell carcinoma Walter M. Stadler Main topic 01 September 2004 Pages: 145 - 146
Specific monoclonal antibody-based immunotherapy by targeting the RCC-associated antigen carbonic anhydrase-IXG250/MN Peter MuldersI. BleumerE. Oosterwijk Main topic 01 September 2004 Pages: 146 - 147
Protein kinase inhibitors: novel tools in cancer therapy D. Marmé Main topic 01 September 2004 Pages: 148 - 148
Genetic pathways and new progression markers for prostate cancer defined by microsatellite allelotyping Rolf von KnoblochLutz KonradRainer Hofmann Main Topic 01 September 2004 Pages: 149 - 152